Skip to main content
OpenTrials
Completed

NCT Number: NCT05657665

Skin Tone Measurement Method Investigation for Pulse Oximetry

The primary objective is to gather missing information in order to form a well-founded recommendation on which is the preferred skin pigmentation measurement (PPM) methods in the context of pulse-oximetry.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–66 year

Sex eligibility

All sexes

Study type

Observational

Primary location

High Tech Campus

Eindhoven, Netherlands

About this study

Skin tone bias in pulse-oximetry (SpO2) needs to be addressed urgently. While skin pigmentation is a prime candidate for the root cause of skin tone bias in SpO2, more research is needed. F A solid comparison and recommendation requires evaluation of several additional aspects that affect accuracy, precision, and reproducibility of the PMMs.

Briefly, these additional aspects that are evaluated in this study are listed below:

  • operator bias
  • impact of operator color blindness
  • probe pressure
  • probe aperture size
  • device stability
  • impact of blood on pigmentation measurement
  • feasibility of skin tone measurement on sides of fingers
  • intra-operator variability

PMMs included in this study are:

Subjective color matching methods by using:

  • Von Luschan color scale
  • Fitzpatrick color scale
  • Pantone color scale

Objective probe-based measurements by using:

  • Konica Minolta CM700d (reflectance spectrometer)
  • Mx18 (erythema-melanin meter)
  • SPA99 (erythema-melanin meter)

Measurements will be performed on 5 relatively light skinned, and 5 relatively dark skinned volunteers (N=10 in total*). The study will be executed on the High-Tech Campus Eindhoven (Netherlands) and each participant will have 3 visits of approximately 1.5 to 2 hours/visit.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (18-65 years)
  • Fluent in either English or Dutch
  • Participants who are willing and able to provide informed consent themselves.
  • People with Von Luschan scores <18 ('light skin' group) or > 25 ('dark skin' group).

Exclusion criteria

  • Skin conditions that could potentially interfere with the measurements:
  • piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
  • vascular or pigmentary or renal psoriasis
  • epidermal bullosum
  • other diseases that affect the skin (tone) of the body
  • COVID-19 exclusion criteria*:
  • Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
  • Having been positively tested as infected with COVID-19 in the past 14 days
  • Travelled to or from high risk COVID-19 areas in the past 14 days
  • Been in contact with a (suspected) COVID-infected person in the past 14 days
  • Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
  • Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
  • Known allergic reaction to facial make-up
  • Usage of tanning sprays/cremes
  • Wearing make-up during the study visits (mascara is allowed)
  • No testing will be performed in the study. Participants will be asked if they have been positively tested.

Treatment and study plan

Observational measurements of skin tone

Other

Objective and subjective skin tone measurements will be performed.

Primary outcomes

  1. Preferred skin PMM in the context of pulse-oximetry.

    Time frame: 10 months

    The primary objective is to complement a previous skin pigmentation study executed by Philips to gather missing information in order to form a well-founded recommendation on which is the preferred skin PPM in the context of pulse-oximetry.

Sponsors and collaborators

Lead sponsor

Philips Electronics Nederland B.V. acting through Philips CTO organization

Industry

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 20, 2022
Registry last updated
Apr 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.